Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2021-01-15
2021-10-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
H1:Carrying load on the dominant hand increases dynamic plantar pressure parameter values.
H0: Carrying load in the dominant hand does not change the dynamic plantar pressure parameter values.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
An Analysis of Plantar Pressure Distribution and Postural Balance Parameters in Individuals With Diabetic Foot Diagnosis
NCT07084922
Plantar Pressure Analysis and Foot Biomechanics in Lipedema and Chronic Venous Disease
NCT06238791
Balance, Plantar Pressure Distribution and Gait in Pes Planus
NCT05240287
The Effects of Postural Changes on Plantar Pressure in Patients With Ankylosing Spondylitis
NCT04820725
Investigation of the Relationship Between Plantar Foot Pressure and Balance in Morbidly Obese Individuals
NCT05519436
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Research Question: The aim of the study was to investigate the effect of loads carried with the dominant and non-dominant hand on dynamic plantar pressure parameters in healthy individuals.
Method: 20 healthy participants aged 20-55 years participated in the study voluntarily. The participants were asked to walk at least six laps at normal walking speed while carrying a load weighing 4 kg with their right and then their left hands. The Sensor Medica pedobarography device was used to evaluate dynamic plantar pressure.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dominant hand
Participants are evaluated only once.
plantar pressure
Healthy individuals carry loads with their dominant and non-dominant hands.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
plantar pressure
Healthy individuals carry loads with their dominant and non-dominant hands.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* without any systemic, neurological, orthopaedic and chronic diseases
Exclusion Criteria
* physical and mental problems
* having balance problems and high risk of falling
* with joint instability
20 Years
55 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medipol University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hande YAZICI
Lecturer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Istanbul Medipol University
Beykoz, Istanbul, Turkey (Türkiye)
Istanbul Medipol University
Istanbul, Istanbul, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HIsci
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.